◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Global Health Limited (MEDANTA)
Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20
Global Health Limited, together with its subsidiaries, provides healthcare services in India.
Cifras clave
- Capitalización bursátil: ₹403 billion
- Ingresos (ejercicio cerrado en 2026-03-31): ₹43.2B
- Beneficio neto: ₹5.6B
- Margen bruto: 76.9%
- Margen neto: 12.9%
Ver gráficos interactivos y estados completos →
Cuenta de resultados anual
| Cuenta de resultados | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| Ingresos totales | ₹43.2B | ₹36.4B | ₹32.4B | ₹26.8B |
| Beneficio bruto | ₹33.2B | ₹27.6B | ₹24.8B | ₹20.6B |
| Ingresos operativos (EBIT) | ₹7.3B | ₹7.4B | ₹6.6B | ₹5.0B |
| Ingresos netos | ₹5.6B | ₹4.8B | ₹4.8B | ₹3.3B |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de MEDANTA. /companies/us/MEDANTA
Empresas similares
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.